Articles with "normal acute" as a keyword



Photo from wikipedia

Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD

Sign Up to like & get
recommendations!
Published in 2017 at "Leukemia"

DOI: 10.1038/leu.2016.343

Abstract: Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3 -ITD or MLL -PTD read more here.

Keywords: normal acute; acute myelogenous; cytogenetically normal; relapse cytogenetically ... See more keywords
Photo from wikipedia

Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant values

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Rheumatic Diseases"

DOI: 10.1111/1756-185x.13469

Abstract: Despite high clinical disease activity, some patients with active rheumatoid arthritis (RA) have normal acute phase reactant (APR) values. This study aimed to determine the clinical outcomes of active RA patients with normal APR values. read more here.

Keywords: normal acute; acute phase; active rheumatoid; patients active ... See more keywords
Photo from wikipedia

A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia

Sign Up to like & get
recommendations!
Published in 2017 at "Oncotarget"

DOI: 10.18632/oncotarget.17151

Abstract: Acute myeloid leukemia is a hematologic malignancy with significant molecular heterogeneity. MicroRNAs have important biological functions and play critical roles in pathogenesis and prognosis in a variety of cancers including acute myeloid leukemia. Some reports… read more here.

Keywords: myeloid leukemia; normal acute; cytogenetically normal; acute myeloid ... See more keywords
Photo from wikipedia

Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia.

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of laboratory medicine"

DOI: 10.3343/alm.2022.42.5.585

Abstract: Cytogenetically normal acute myeloid leukemia (CN-AML) accounts for 40%-50% of all AML cases. Despite advances in understanding the molecular pathophysiology of CN-AML, its clinical outcome remains unsatisfactory and unpredictable. To investigate its clinical implication in… read more here.

Keywords: myeloid leukemia; acute myeloid; associated adverse; normal acute ... See more keywords